<DOC>
	<DOCNO>NCT02625870</DOCNO>
	<brief_summary>The trial double-blind , randomize , parallel-group study compare Omega-3-Acid Ethyl Esters 90 Soft Capsules placebo . The primary objective present study evaluate efficacy safety Omega-3-Acid Ethyl Esters 90 Soft Capsules subject severe hypertriglyceridemia ( TGs ≥500 mg/dL ＜2000 mg/dL ) .</brief_summary>
	<brief_title>Omega-3-Acid Ethyl Esters 90 Soft Capsules Lowering Very High Triglycerides</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>1.At least 2 time fast serum TG concentrations≥500 mg/dL but＜2000 mg/dL screening ( 2and 1 0 week random assignment ) . 2.Two time qualified High Triglycerides Dietary Assessment Table 2 0 week random assignment accord `` prevention treatment dyslipidemia Chinese adult Guide `` . 1.Unable discontinue use omega3 fatty acidcontaining product , bile acid sequestrants , fibrates , niacin supplement use alter lipid metabolism throughout entire study . 2.Patients take bile acid sequestrants , fibrate , niacin supplement use alter lipid metabolism 6 week enter study dietary phase . 3.Subjects consume omega3 fatty acidcontaining product cod liver oil , lipiddecreasing fiber least 4 week begin study . 4.Serum alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) ＞3 time upper limit normal . 5.Serum creatinine ＞176μmol/L . 6.Platelet counts＜60×109/L，hemoglobin ＜100 g/L . 7.Poorly controlled hypertension ( rest blood pressure ≥160 mm Hg systolic ≥100 mm Hg diastolic ) 8.Uncontrolled type II diabetes ( fast blood sugar ＞11.1mmol/L ) . 9.Type II diabetes , nephrotic syndrome , hypothyroidism . 10.Atrial fibrillation . 11.History pancreatitis symptomatic gallstone disease , unless treat cholecystectomy . 12.History cancer ( basal cell carcinoma ) past 2 year . 13.Allergy intolerance omega3 fatty acid , omega3acid ethyl ester , fish . 14.History past 12 month drug abuse alcohol abuse ( .14 drink per week ; 1 drink equivalent 12 oz beer , 5 oz wine , 1.5 oz hard liquor ) also exclusionary . 15.Exposure investigational product , within 30 day prior Visit . 16.Presence condition Investigator believe would interfere study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>